Australia News
-
Top 20: AUSTRALIA - Achieves marginal growth
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 07 Jul, 2014
With 11 percent share and $11.65 billion is revenue, Australia grew marginally. It has been a bad year or Australia's...Read more
-
Mayne Pharma to buy Doryx from Actavis
Australia | News | By BioSpectrum Bureau | 0 Comment | 11 Feb, 2015
Singapore: Australia-based Mayne Pharma has struck a deal to acquire Doryx acne-treatment brand and assets in the US for...Read more
-
Australia's Orthocell gets Chinese patent for scaffold technology
Australia | News | By BioSpectrum Bureau | 0 Comment | 16 Jan, 2015
Singapore: Australia's regenerative medicine company, Orthocell, has recieved Chinese patent for its Collagen Scaffold f...Read more
-
SII seeks WHO consent to export flu vaccines
Australia | News | By BioSpectrum Bureau | 0 Comment | 12 Dec, 2012
Singapore: Serum Institute of India (SII) has applied for permits to export flu vaccines produced using Australia's BioD...Read more
-
QRxPharma refiles Moxduo NDA with FDA
Australia | News | By BioSpectrum Bureau | 0 Comment | 26 Nov, 2013
Singapore: Australia-based QRxPharma has resubmitted its Moxduo new drug application (NDA) after the US Food and Drug Ad...Read more
-
Japan's NEC to exploit Prima BioMed's cancer immunotherapeutic technology
Australia | News | By BioSpectrum Bureau | 0 Comment | 12 May, 2015
The press release indicated that Immutep is a French company and is a 100 percent subsidiary of Prima BioMed. Immutep de...Read more
-
Phosphagenics to start opioid pain patch study
Australia | News | By BioSpectrum Bureau | 0 Comment | 03 Dec, 2012
Singapore: Melbourne-based Phosphagenics has resolved all crystallisation issues associated with its opioid patch devel...Read more
-
Australia to finalize a policy on naming biosimilars
Australia | News | By BioSpectrum Bureau | 0 Comment | 22 Jan, 2015
Singapore: In July 2013, Therapeutics Goods Administration, Australia, had published a guidance on biosimlar naming base...Read more
-
Australia | News | By BioSpectrum Bureau | 0 Comment | 16 Jan, 2015
Singapore: Australia based Novotech has strengthened its Hong Kong operation with expansion of its manpower base. The c...Read more
-
Bridge to the DNA vaccine dream
Australia | News | By BioSpectrum Bureau | 0 Comment | 06 Jun, 2012
Can DNA vaccines be the answer to diseases such as malaria and influenza? Though DNA-based vaccines have emerged as appe...Read more
-
AirStrip enters the Australian market
Australia | News | By BioSpectrum Bureau | 0 Comment | 19 Feb, 2015
Singapore: US-based AirStrip recently inked a pact with Life Monitor, a subsidiary of Cardioscan, to sell AirStrip solut...Read more
-
No vaccination, No benefits, says Australian PM
Australia | News | By BioSpectrum Bureau | 0 Comment | 21 Apr, 2015
Singapore: Australian government has recently made an announcement that parents who refuse to vaccinate their children m...Read more
-
Vaxxas' Nanopatch is the future of needle-free vaccine
Australia | Influencers | By Piyusha Chatterjee | 3 Comment | 17 Oct, 2012
One of the challenges in the R&D of next generation vaccines is the development of a delivery technology that will b...Read more
-
The unconventional side of vaccines
Australia | Opinion | By BioSpectrum Bureau | 0 Comment | 23 Jul, 2012
When we talk about vaccines, most people think of an injection to prevent childhood infectious disease. However, in rece...Read more
-
Viralytics melanoma trial meets primary endpoint
Australia | News | By BioSpectrum Bureau | 0 Comment | 18 Sep, 2013
Singapore: Australia-based biotech company, Viralytics, achieved the primary endpoint in its phase II clinical trial of ...Read more
-
QRxPharma, Paladin sign $25.5 mn morphine deal
Australia | News | By BioSpectrum Bureau | 0 Comment | 10 Oct, 2012
Singapore: Australia's QRxPharma has collaborated with Canadian specialty pharmaceutical company, Paladin Labs on licens...Read more
-
BioAsia 2014: Innovation, collaboration identified as success keys
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 05 Mar, 2014
Hyderabad: With emphasis on cutting-edge innovations this year, BioAsia 2014 under the theme 'Innovate. Evolve.' kick-st...Read more
-
Gilead commercial operations head to retire
Australia | News | By BioSpectrum Bureau | 0 Comment | 08 Jan, 2014
Singapore: Gilead Sciences' head of commercial operations for the past decade, Mr Kevin Young, who oversaw tremendous sa...Read more
